Your browser doesn't support javascript.
loading
Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?
Owen-Schaub, L B; Angelo, L S; Radinsky, R; Ware, C F; Gesner, T G; Bartos, D P.
Affiliation
  • Owen-Schaub LB; Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Cancer Lett ; 94(1): 1-8, 1995 Jul 20.
Article in En | MEDLINE | ID: mdl-7542559
ABSTRACT
Fas/APO-1, a member of the NGF/TNF receptor superfamily expressed on the cell-surface of normal and malignant cells, is known to induce cell death by apoptosis. In the present study, we have investigated Fas/APO-1 gene defects in a human osteosarcoma cell line resistant to the apoptosis-inducing effects of anti-Fas. cDNA cloning and sequencing revealed that these cells contained both 'authentic' and mutant Fas/APO-1 containing a 63 base pair in-frame deletion spanning the transmembrane domain, designated DFas/APO-1. Direct evidence for the existence of a soluble Fas/APO-1 protein was obtained by immunoprecipitation and Western blotting. Taken together with prior studies demonstrating a role for Fas/APO-1 and Fas ligand, respectively, in tumor target cell killing by cytotoxic T-lymphocytes, production of soluble Fas/APO-1 might have significant implications in malignant disease pathogenesis.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Osteosarcoma / Gene Deletion / Apoptosis / Antigens, Surface Limits: Humans Language: En Journal: Cancer Lett Year: 1995 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Osteosarcoma / Gene Deletion / Apoptosis / Antigens, Surface Limits: Humans Language: En Journal: Cancer Lett Year: 1995 Type: Article Affiliation country: United States